These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9008951)

  • 21. Universal hepatitis A vaccination in the United States: a call for action.
    Lieberman JM; Word BM; Jacobs RJ; Dagan R; Marchant CD
    Pediatr Infect Dis J; 2008 Apr; 27(4):287-91. PubMed ID: 18316993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Viral hepatitis: preventable illnesses].
    Baumgarten R
    Z Arztl Fortbild Qualitatssich; 1998 Dec; 92(10):677-80. PubMed ID: 10028595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C.
    Myers RP; Gregor JC; Marotta PJ
    Hepatology; 2000 Apr; 31(4):834-9. PubMed ID: 10733536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seroprevalence of hepatitis A virus markers in Eastern Saudi Arabia.
    Fathalla SE; Al-Jama AA; Al-Sheikh IH; Islam SI
    Saudi Med J; 2000 Oct; 21(10):945-9. PubMed ID: 11369959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis A in Australia in the 1990s: future directions in surveillance and control.
    Amin J; Heath T; Morrell S
    Commun Dis Intell; 1999 May; 23(5):113-20. PubMed ID: 10429311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hepatitis vaccination of adults].
    Jost R
    Schweiz Med Wochenschr; 1998 Jul; 128(27-28):1104-9. PubMed ID: 9691345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis A: disease burden and current childhood vaccination strategies in the United States.
    Koslap-Petraco MB; Shub M; Judelsohn R
    J Pediatr Health Care; 2008; 22(1):3-11. PubMed ID: 18174084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Person-to-person transmission of hepatitis A virus in an urban area of intermediate endemicity: implications for vaccination strategies.
    Victor JC; Surdina TY; Suleimenova SZ; Favorov MO; Bell BP; Monto AS
    Am J Epidemiol; 2006 Feb; 163(3):204-10. PubMed ID: 16339053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of prescreening versus empirical vaccination for hepatitis A in Egyptian children with chronic liver disease.
    El-Karaksy H; El-Sayed R; El-Raziky M; El-Koofy N; Mansour S
    East Mediterr Health J; 2008; 14(4):804-9. PubMed ID: 19166163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute hepatitis A in Italy: incidence, risk factors and preventive measures.
    Tosti ME; Spada E; Romanò L; Zanetti A; Mele A;
    J Viral Hepat; 2008 Oct; 15 Suppl 2():26-32. PubMed ID: 18837830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical trial to evaluate immunogenicity and safety of inactivated hepatitis A vaccination starting at 2-month-old children.
    Kanra G; Yalçin SS; Ceyhan M; Yurdakök K
    Turk J Pediatr; 2000; 42(2):105-8. PubMed ID: 10936974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A cost-effectiveness analysis of universal childhood hepatitis A vaccination in China.
    Zhuang GH; Pan XJ; Wang XL
    Vaccine; 2008 Aug; 26(35):4608-16. PubMed ID: 18597903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An individual-based model of hepatitis A transmission.
    Ajelli M; Merler S
    J Theor Biol; 2009 Aug; 259(3):478-88. PubMed ID: 19361529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology of endemic viral hepatitis in an urban area of India: a retrospective community study in Alwar.
    Singh J; Prakash C; Gupta RS; Bora D; Jain DC; Datta KK
    Bull World Health Organ; 1997; 75(5):463-8. PubMed ID: 9447780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effective analysis of hepatitis A prevention in Ireland.
    Rajan E; Shattock AG; Fielding JF
    Am J Gastroenterol; 2000 Jan; 95(1):223-6. PubMed ID: 10638588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
    Tilson L; Thornton L; O'Flanagan D; Johnson H; Barry M
    Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis A: epidemiology and prevention.
    Feinstone SM
    Eur J Gastroenterol Hepatol; 1996 Apr; 8(4):300-5. PubMed ID: 8781894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hepatitis-A vaccination in children].
    Gendrel D
    Med Trop (Mars); 2004; 64(4):394-400. PubMed ID: 15615396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The shifting epidemiology of hepatitis A following routine childhood immunization program in Israel.
    Chodick G; Green MS; Heymann AD; Rosenmann L; Shalev V
    Prev Med; 2007 Nov; 45(5):386-91. PubMed ID: 17599401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunogenicity and efficacy trials of live attenuated hepatitis A vaccines].
    Xu Z; Li R; Meng Z
    Zhonghua Yi Xue Za Zhi; 1998 Apr; 78(4):254-6. PubMed ID: 10923477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.